Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01555606 · ClinicalTrials.gov registry record
An Observational Study to Evaluate Patient-Reported Experiences of Living With Moderate-to-Severe Plaque Psoriasis
A clinical trial, sponsored by Janssen Biotech.
- Completed
- Registry status
- 108
- Enrollment target
NCT01555606 is a clinical trial that has completed, run by Janssen Biotech. The registered enrollment target is 108 participants.
The verdict
NCT01555606 has completed, sponsored by Janssen Biotech.
- COMPLETED
- Registry status
- 108 participants
- Enrollment target
Study Summary
The purpose of the study is to develop a database containing patient-reported information that may be used to understand and to increase awareness of the impact that moderate-to-severe plaque psoriasis can have on both daily life and life in general from a patient's perspective. The database will include self-reported patient narratives on the topic of the experience of having moderate-to-severe plaque psoriasis and will include information on treatments received, as well as de-identified clinical photographs taken over the course of the disease.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2011-06 |
| Est. Completion | 2012-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01555606
The ClinicalTrials.gov registry entry for NCT01555606 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Janssen Biotech, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT01555606 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01555606 about?
NCT01555606 is a clinical study titled "An Observational Study to Evaluate Patient-Reported Experiences of Living With Moderate-to-Severe Plaque Psoriasis". The purpose of the study is to develop a database containing patient-reported information that may be used to understand and to increase awareness of the impact that moderate-to-severe plaque psoriasis can have on both daily life and life in general from a patient's perspective. The database will in...
What is the current status of trial NCT01555606?
This trial is currently completed. The enrollment target is 108 participants. The study started on 2011-06. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01555606?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT01555606?
This trial is sponsored by Janssen Biotech, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.